Department of Biostatistics and Translational Medicine
Paper
Despite significant progress in oncology in recent decades, only about 50% of patients with invasive bladder cancer (MIBC) affecting the muscle layer, survive five years after diagnosis. New hope comes from the combination of radiochemotherapy with the rapidly advancing field of immunotherapy. A member of our team, and a specialist in oncological radiotherapy from the […]
Breast cancer is the most common cancer in women. In 2020, 2.3 million new cases were diagnosed, accounting for 11.7% of new cancer diagnoses worldwide. Approximately 5% – 10% of cases involve hereditary breast and ovarian cancer (HBOC), most commonly linked to mutations in the BRCA1 or BRCA2 genes. Currently, BRCA1/2 genetic tests are recommended […]
We are happy to inform about our team member, Dr. Bartłomiej Tomasik, tremendous achievement – the co-discovery of a new DNA repair mechanism. Dr. Bartłomiej Tomasik is a co-author of the article that describes the newly discovered mechanism for repairing double-strand DNA breaks. The work has been published in the prestigious journal ‘Nature Structural & […]
We are pleased to announce that the results of our research in collaboration with Dana Farber Cancer Institute, Maria Skłodowska-Curie National Research Institute of Oncology in Gliwice and Wrocław Medical University have been published in Radiotherapy&Oncology. Our study provides compelling evidence that specific microRNAs in serum can serve as reliable indicators of radiation exposure and […]
We are pleased to announce that the results of our research in collaboration with the Dana-Farber Cancer Institute have been published in Nature Communications! In this publication, we focused on the application of microRNAs for the identification of BRCA1 and BRCA2 gene mutations without DNA sequencing. The developed test does not rely on direct verification […]
We are pleased to inform about the success of our Ph.D. student Damian Mikulski, M.D. – the results of the ATLAS clinical trial (PMC006) in which he participated were published in the Lancet Oncology (IF 54.433) in the manuscript “Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients […]
We are pleased to inform about the publication of our new article “GlyCulator 3.0: A Fast, Easy-to-Use Analytical Tool for CGM Data Analysis, Aggregation, Center Benchmarking, and Data Sharing” in the Diabetes Care (IF: 19,110). Main authors of the work, performed in cooperation with clinicians from Department of Pediatrics, Diabetology, Endocrinology and Nephrology, Medical University […]
When searching for a given term in Wikipedia, have you ever wondered what drives your interest in this article? Does anyone else share your interests and enter the same term at this time? Can we investigate it, and if so, can we take advantage of it? And what does the COVID-19 pandemic have to do […]
We are happy to present the results of our fruitful collaboration with researchers from University of Bern, Switzerland and from the Netherlands Cancer Institute. Zuzanna Nowicka and Wojciech Fendler MD PhD co-authored the article Functional Radiogenetic Profiling Implicates ERCC6L2 in Non-homologous End Joining in the August issue of Cell Reports. In this study, genome-wide radiogenetic […]
Urszula Smyczyńska PhD and Wojciech Fendler MD PhD in cooperation with scientists from Polish Academy of Sciences and from University of Warsaw have published a paper entitled TP53-Deficient Angiosarcoma Expression Profiling in Rat Model in Cancers journal (IF 6.37) Angiosarcoma is a tumor from the group of sarcomas – malignant tumors which develop from mesenchymal […]
